Aegis Medicines Pvt Ltd
About Aegis Medicines Pvt Ltd
Data last updated:
Aegis Medicines Pvt Ltd is a private limited company based in Pune, Maharashtra, India, a subsidiary of Aegis Ampoules And Vials Limited. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 July 1993.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U99999PN1993PTC073083. Its GSTIN is 27AABCA5760B1Z2 (Maharashtra).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹6.24 Cr. It is led by directors including Girish Siriram Juneja (Irp/Rp/Liquidator) and Mukesh Khathuria (Irp/Rp/Liquidator).
Its last annual general meeting (AGM) was held on 16 August 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at A – 502 Kumar Gulmohar Cts No. 1436 Survey No. 70A/1/2/2B Wanowrie Pune 4110, 40., Maharashtra, India – 411040.
As per MCA filings, the company has open charges of ₹55.24 Cr and satisfied charges of ₹55.24 Cr on record. Court records list 11 cases involving the company, including 5 filed by the company and 6 filed against it; 2 cases are pending.
Company details
Contact details
Aegis Medicines Pvt Ltd's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 502 Kumar Gulmohar Cts No. 1436 Survey No. 70A/1/2/2B Wanowrie Pune 4110, 40., Maharashtra, India – 411040
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aegis Medicines Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aegis Medicines is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Aegis Medicines Pvt Ltd
FY 2022 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aegis Medicines Pvt Ltd, buy the company report.
Board of directors of Aegis Medicines Pvt Ltd
Aegis Medicines has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Siriram Juneja | Irp/Rp/Liquidator | 06 Apr 2023 | 3 Years 7 Months | As last reported |
| Mukesh Khathuria Also directs: Saviour Insolvency Professionals LLP | Irp/Rp/Liquidator | 18 Sep 2024 | 2 Years 1 Months | As last reported |
| Ayub Gaffar Syed | Director | 23 Jul 1993 | 33 Years 3 Months | As last reported |
| Ayesha Ayub Syed | Director | 23 Jul 1993 | 33 Years 3 Months | As last reported |
Auditor
Aegis Medicines Pvt Ltd is audited by GILDA MANTRI GHAL & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GILDA MANTRI GHAL & Associates | FY 2022 | 139193W |
Shareholding
The shareholding of Aegis Medicines Pvt Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aegis Medicines Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jan 2013 | 10406822 | State Bank of India | ₹32.02 Cr | Satisfied | |
| 31 Dec 2009 | 10199259 | State Bank of India | ₹23.22 Cr | Satisfied |
To see the full charge records of Aegis Medicines Pvt Ltd, buy the company report.
Total charge records: 2 View all charges
Legal cases
Aegis Medicines Pvt Ltd has 11 court cases on record: 5 filed by Aegis Medicines, 6 filed against it. 2 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 5 | 2 |
| High courts | 3 | 1 | 0 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Aurangabad, Maharashtra | Court case (Civil M.A.) | Filed by the company against Silver Jubilee Infrastructure Ltd. | Pending |
| Bombay High Court | Writ petition | Filed against the company by Silver Jubilee Infrastructure Limited THR. Its Director | Disposed |
| District court, Aurangabad, Maharashtra | Court case (Reg Dkst) | Filed against the company by an individual | Pending |
| District court, Aurangabad, Maharashtra | Court case (Reg Dkst) | Filed against the company by an individual | Disposed |
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Govt.Of India---Roc--- and 2 others | Disposed |
To see the full case history of Aegis Medicines Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aegis Medicines Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aegis Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCA5760B1Z2 | Maharashtra | Active | 16 Dec 2024 |
To see the full GST registrations and return filing status of Aegis Medicines Pvt Ltd, buy the company report.
Recent activity
Aegis Medicines Pvt Ltd has 5 board changes on record since 1993: 4 appointments and 1 cessation. The latest: Mukesh Khathuria was appointed as Irp/Rp/Liquidator on 18 Sep 2024.
1 earlier event is in the company report.
Frequently asked questions
Aegis Medicines is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Aegis Medicines is a company under liquidation, formerly operating as a private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 July 1993 and is registered under CIN U99999PN1993PTC073083. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Aegis Medicines has 4 current directors:
- Ayub Gaffar Syed - Director
- Ayesha Ayub Syed - Director
- Girish Siriram Juneja - Irp/Rp/Liquidator
- Mukesh Khathuria - Irp/Rp/Liquidator
The latest financial statements of Aegis Medicines on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 16 August 2022. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Aegis Medicines is U99999PN1993PTC073083. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aegis Medicines has open charges of ₹55.24 Cr and satisfied charges of ₹55.24 Cr as per latest MCA filings.
Aegis Medicines has 11 court cases on record: 5 filed by the company and 6 filed against it. 2 are pending. Most are in the district courts.
Aegis Medicines was incorporated on 23 July 1993. It is registered with the Registrar of Companies, Pune.
Mukesh Khathuria was appointed as Irp/Rp/Liquidator on 18 Sep 2024. Girish Siriram Juneja was appointed as Irp/Rp/Liquidator on 06 Apr 2023. Raziuddin Bashiruddin Shaikh ceased to be Director on 15 Jun 2009. Aegis Medicines has 5 board changes on record in total.
The registered office of Aegis Medicines is at A – 502 Kumar Gulmohar Cts No. 1436 Survey No. 70A122B Wanowrie Pune 4110, 40., Maharashtra, India – 411040.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
